Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of GBP 2.50 billion. The enterprise value is 3.55 billion.

Market Cap	2.50B
Enterprise Value	3.55B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.00M

Valuation Ratios

The trailing PE ratio is 180.67.

PE Ratio	180.67
Forward PE	n/a
PS Ratio	1.44
PB Ratio	6.17
P/TBV Ratio	n/a
P/FCF Ratio	21.61
P/OCF Ratio	11.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.47, with an EV/FCF ratio of 30.78.

EV / Earnings	257.27
EV / Sales	1.90
EV / EBITDA	15.47
EV / EBIT	54.17
EV / FCF	30.78

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 2.53.

Current Ratio	0.79
Quick Ratio	0.64
Debt / Equity	2.53
Debt / EBITDA	4.83
Debt / FCF	8.87
Interest Coverage	1.24

Financial Efficiency

Return on equity (ROE) is 2.87% and return on invested capital (ROIC) is 2.81%.

Return on Equity (ROE)	2.87%
Return on Assets (ROA)	2.24%
Return on Invested Capital (ROIC)	2.81%
Return on Capital Employed (ROCE)	4.66%
Revenue Per Employee	36,606
Profits Per Employee	292
Employee Count	47,256
Asset Turnover	1.03
Inventory Turnover	25.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.06% in the last 52 weeks. The beta is 1.52, so Medicover AB's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+61.06%
50-Day Moving Average	202.95
200-Day Moving Average	192.79
Relative Strength Index (RSI)	59.25
Average Volume (20 Days)	1,324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of GBP 1.73 billion and earned 13.81 million in profits. Earnings per share was 0.09.

Revenue	1.73B
Gross Profit	370.73M
Operating Income	60.53M
Pretax Income	16.62M
Net Income	13.81M
EBITDA	141.58M
EBIT	60.53M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 68.47 million in cash and 1.02 billion in debt, giving a net cash position of -956.06 million.

Cash & Cash Equivalents	68.47M
Total Debt	1.02B
Net Cash	-956.06M
Net Cash Per Share	n/a
Equity (Book Value)	404.64M
Book Value Per Share	2.56
Working Capital	-98.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 216.58 million and capital expenditures -101.14 million, giving a free cash flow of 115.44 million.

Operating Cash Flow	216.58M
Capital Expenditures	-101.14M
Free Cash Flow	115.44M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.43%, with operating and profit margins of 3.50% and 0.80%.

Gross Margin	21.43%
Operating Margin	3.50%
Pretax Margin	0.96%
Profit Margin	0.80%
EBITDA Margin	8.18%
EBIT Margin	3.50%
FCF Margin	6.67%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.10
Dividend Yield	0.05%
Dividend Growth (YoY)	-3.01%
Years of Dividend Growth	n/a
Payout Ratio	107.78%
Buyback Yield	-0.36%
Shareholder Yield	-0.32%
Earnings Yield	0.55%
FCF Yield	4.63%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	n/a